Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial
-
Published:2023-08
Issue:4
Volume:8
Page:101611
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Ferreiro-Pantín M.,
Anido-Herranz U.,
Betancor Y.Z.,
Cebey-López V.,
León-Mateos L.,
García-González J.,
García-Acuña S.M.,
Fernández-Díaz N.,
Tubio J.M.C.,
López-López R.,
Ruiz-Bañobre J.ORCID
Subject
Cancer Research,Oncology